LyMa-101 trial update: Obinutuzumab for the treatment of mantle cell lymphoma
Summary of the updated results from the phase II LyMA-101 trial evaluating obinutuzumab plus high-dose cytarabine for the treatment of transplant-eligible patients with MCL.
Phase I trial of the triplet therapy ipilimumab, nivolumab, and brentuximab vedotin for patients with relapsed/refractory Hodgkin lymphoma
A summary of the results from a phase I clinical trial evaluating immune checkpoint inhibition with ipilimumab...
" The Lymphoma Hub allows you to navigate the most relevant and up-to-date information in lymphoma and CLL. From recently published papers to on-site interviews, we aim to deliver valuable data to all physicians practicing hemato-oncology. "
Your opinion matters